To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2322 | Gramibactin |
Bacterial siderophore with a diazeniumdiolate ligand system
More description
|
|
| DCC2321 | Gr-65630 |
5-HT3 receptor antagonist
More description
|
|
| DCC2320 | Gr-55562 Dihydrobromide |
5-HT1B/5-HT1D serotonin receptor antagonist
More description
|
|
| DCC2319 | Gr269666a |
Novel inhibitor of the EGFr and C-erbB-2.
More description
|
|
| DCC2318 | gr-205171 Dihydrochloride |
Selective and brain penetrant NK1-receptor antagonist
More description
|
|
| DCC2317 | Gr134056x |
Negative control for GI181771X
More description
|
|
| DCC2316 | Gr105659x |
Potent TrkA kinase inhibitor
More description
|
|
| DCC2315 | G-quadruplex/i-motif Binder A9 |
Novel dual G-quadruplex/i-motif binder, binding to and stabilizing both G-quadruplex and i-motif, being effective in both oncogene replication and transcription
More description
|
|
| DCC2314 | Gqc-05 |
Novel high affinity, potent, and selective stabilizer of the MYC G-quadruplex (G4)., inducing cytotoxicity with corresponding decreased MYC mRNA and altering protein binding to the NHE III1 region
More description
|
|
| DCC2313 | Gpx4-in-26a |
Novel potent and selective ferroptosis inducer, inhibiting glutathione peroxidase 4 (GPX4)
More description
|
|
| DCC2312 | Gps488 |
Novel HIV replication blocker (EC 50 = 1.66 μM), being actively against a panel of HIV mutant strains displaying resistance to individual drugs used in antiretroviral therapy
More description
|
|
| DCC2311 | Gpr88-agonist-84 |
Novel potent GPR88 agonist (EC 50 = 59 nM)
More description
|
|
| DCC2310 | Gpr88 Agonist 53 |
Novel, potent, efficacious, and brain-penetrant GPR88 agonist (cAMP EC 50 = 14 nM)
More description
|
|
| DCC2309 | Gpr52-in-43 |
Highly potent and specific GPR52 antagonist
More description
|
|
| DCC2308 | Gpr52-agonist-1b |
The first orally active GPR52 agonist
More description
|
|
| DCC2307 | Gpr52-agonist-17 |
Novel potent GPR52 agonist, dose-dependently suppressing methamphetamine-induced hyperlocomotion in mice
More description
|
|
| DCC2306 | Gpr120-agonist-6a |
Novel potent GPR120 agonist, exhibiting significant glucose-lowering effect and high selectivity over GPR40
More description
|
|
| DCC2305 | Gpi-15427 |
Potent PARP inhibitor
More description
|
|
| DCC2304 | Gpbar1-agonist-10 |
Novel selective non-steroidal agonist of G-protein bile acid receptor 1 (GPBAR1, also known as TGR5 or M-BAR)
More description
|
|
| DCC2303 | Go-y030 |
Curcumin analog, exhibiting potent growth suppressive activity in human colorectal carcinoma cells
More description
|
|
| DCC2302 | Govaniadine |
Natural potent inducer of apoptosis in MCF-7 cell lines
More description
|
|
| DCC2301 | Govadine |
Antipsychotic and cognitive enhancer; Dopamine D1 and D2 receptor modulator
More description
|
|
| DCC2300 | Gossypolone |
Natural inhibitor of Musashi family of RNA-binding proteins
More description
|
|
| DCC2299 | Gonadorelin Acetate |
Agonist of the GnRH receptor, inducing the secretion of the gonadotropins follicle-stimulating hormone and luteinizing hormone from the pituitary gland and to increase sex hormone production by the gonads
More description
|
|
| DCC2298 | Go/ldha-in-7 |
Dual Glycolate Oxidase/Lactate Dehydrogenase A (GO/LDHA) Inhibitor for Primary Hyperoxaluria
More description
|
|
| DCC2297 | Gnmt Inducer K-117 |
Novel potent GNMT inducer, inhibiting Huh7 cell growth in vitro and xenograft in vivo
More description
|
|
| DCC2296 | Gnlpt-in-1 |
Novel inhibitor of Gram-negative lipoprotein trafficking
More description
|
|
| DCC2295 | Gnidimacrin |
Natural highly potent HIV latency-reversing agent
More description
|
|
| DCC2294 | gnf-pf-3834 |
Dose dependent up-regulator of the level of E-cadherin in SW620 cells
More description
|
|
| DCC2293 | Gnf-pf-3600 |
Novel inhibitor of Plasmodium falciparum, killing both blood- and sexual-stage P. falciparum parasites
More description
|
|